Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase ‐4 inhibitors: A population‐based cohort study using Japanese Latter‐Stage Elderly Healthcare Database

ConclusionsNot all the DPP-4 inhibitors could induce bullous pemphigoid significantly. Therefore, the association warrants further investigations before generalization.

Source: Journal of Diabetes Investigation - March 10, 2023 Category: Endocrinology Authors: Yumi Harano, Yasutaka Mitamura, Peng Jiang, Takako Fujita, Akira Babazono Tags: Original Article Source Type: research